Ballas Christos, Staab Jeffrey P, Evans Dwight L
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Psychopharmacol Bull. 2002 Autumn;36(4):39-62.
Approximately 30% of patients with major depression respond poorly to treatment with any given antidepressant regimen, and as many as 60% to 75% experience residual or recurrent symptoms. Strategies for improving response include extending the duration of each treatment beyond the usual 2-4 weeks, increasing the antidepressant dose, switching to another antidepressant, using two or more antidepressants together, and using adjunctive medications or other treatment modalities. Some of these strategies have strong support from clinical investigations while others are based more on clinical experience. This article reviews the risk factors for treatment resistance and provides strategies for improving treatment outcomes.
约30%的重度抑郁症患者对任何给定的抗抑郁治疗方案反应不佳,多达60%至75%的患者会出现残留症状或复发症状。改善反应的策略包括将每次治疗的持续时间延长至通常的2 - 4周以上、增加抗抑郁药剂量、换用另一种抗抑郁药、联合使用两种或更多种抗抑郁药以及使用辅助药物或其他治疗方式。其中一些策略有临床研究的有力支持,而其他策略更多基于临床经验。本文回顾了治疗抵抗的危险因素并提供了改善治疗结果的策略。